Imunon (IMNN) Operating Margin (2017 - 2022)

Imunon (IMNN) has 6 years of Operating Margin data on file, last reported at 5541.4% in Q4 2022.

• Quarterly Operating Margin fell 1819446.0% year-over-year to 5541.4% in Q4 2022, while the trailing twelve-month figure through Dec 2022 was 4984.31% (down 504431.0% YoY) and the FY2022 annual result came in at 4984.31%, down 504431.0% from the prior year.
• Operating Margin declined to 5541.4% in Q4 2022, from 4939.65% in the prior quarter.
• In the past five years, Operating Margin ranged from a high of 23451.74% in Q4 2018 to a low of 6409.08% in Q2 2018.
• A 5-year average of 716.32% and a median of 3968.84% in 2021 frame the typical range for Operating Margin.
• Annual changes were most pronounced in 2018 — Operating Margin jumped 2719670 bps — and 2020, when it sank 2624933 bps.
• Tracing IMNN's Operating Margin over 5 years: stood at 23451.74% in 2018, then decreased by 4 bps to 22414.25% in 2019, then tumbled by 117 bps to 3835.09% in 2020, then jumped by 430 bps to 12653.06% in 2021, then sank by 144 bps to 5541.4% in 2022.
• The last three Operating Margin figures came in at 5541.4% (Q4 2022), 4939.65% (Q3 2022), and 4782.62% (Q2 2022), per Business Quant data.